Frogs have made significant contributions to Fred Hutch science over the years as a model organism that shares much of our ...

Why are lobular breast cancers found at later stages? What are the biological hallmarks of this disease? Are there ways to ...

Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they explained how U.S.-funded ...

The Fred Hutch News team is embarking on a dynamic storytelling evolution to respond to the changing information landscape.

Cancer Center’s goal is to do more than just provide medical care to every patient. Providers and staff strive to educate ...

After being diagnosed and treated for breast cancer three separate times, Liza Bernstein, 51, of Los Angeles has her life, her family and friends, her hopes and dreams, her art, and a renewed sense of ...

AWS, Deloitte, Microsoft and NVIDIA bring the latest in AI technology, coordination, and compute to the alliance and back with initial funding SEATTLE – Oct. 2, 2024 – Four National Cancer ...

HICOR’s (Hutchinson Institute for Cancer Outcomes Research) Value in Cancer Care Summit is a full-day conference to convene individuals from across the healthcare spectrum to collaborate on ways to ...

People of any age who are diagnosed with cancer can improve strength, function, and independence during and after cancer treatment with the help of physical therapy. Physical therapists help with ...

Patients and caregivers in the Patient and Family Engagement program provide crucial insights regarding the patient experience and how it can be improved. Now that program has expanded to actively ...

Medical oncologist Heather Parsons, MD, MPH, witnessed how cancer affects the entire family when her younger sister was diagnosed with lymphoma as a young adult. It’s an experience that helped her ...

The good news? Enrollment in new cancer therapy clinical trials has returned to normal, at least within one large trial network, a year after the pandemic began. The bad news? Normal trial enrollment ...